Singapore markets closed

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.2100-0.6600 (-23.00%)
At close: 04:00PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
149
-5,263
-44,078
-51,647
-77,802
-
Depreciation & amortisation
-
0
65
472
2,297
-
Stock-based compensation
822
1,067
6,252
9,611
14,992
-
Change in working capital
-5,425
-4,601
-2,850
1,408
-7,592
-
Accounts receivable
-
96
4
27
1,346
-
Accounts payable
-3,183
-1,772
1,142
393
-1,096
-
Other working capital
-16,902
-21,245
-40,611
-36,524
-74,014
-
Other non-cash items
-
-
-
881
-1,669
-
Net cash provided by operating activities
-16,902
-21,245
-40,611
-36,517
-72,490
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-7
-1,524
-6,888
Net cash used for investing activities
-
10,402
0
1,457
18
-
Cash flows from financing activities
Common stock issued
-
-
0
30,503
24,250
175,000
Other financing activities
-
-
-
-
-
36,061
Net cash used provided by (used for) financing activities
-
5,024
29
30,785
28,090
-
Net change in cash
-1,473
-5,811
-40,579
-4,271
-44,389
-
Cash at beginning of period
7,169
13,382
53,961
58,232
102,621
-
Cash at end of period
5,693
7,571
13,382
53,961
58,232
-
Free cash flow
Operating cash flow
-16,902
-21,245
-40,611
-36,517
-72,490
-
Capital expenditure
-
-
-
-7
-1,524
-6,888
Free cash flow
-16,902
-21,245
-40,611
-36,524
-74,014
-